Home

About Us

Publications

PhO in the Media

Our Conferences

Resources

Pharma-Free CME

Teaching Tools

News Archive

Drug Industry

Contact Us

How You Can Help

NEWS FEED

PharmedOut Publications and Other Materials

Journal Articles

Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women's Health Initiative: An Analysis of Published Articles
PLoS Medicine

Why Lunch Matters
The Journal of Continuing Education in the Health Professions Assessing physicians' perceptions about industry relationships

The Haunting of Medical Journals
PLoS Medicine
How Ghostwriting Sold “HRT”

Do New Drugs Increase Life Expectancy?
Journal of General Internal Medicine
A critique of a Manhattan Institute paper

Ethical Considerations of Publication Planning in the Pharmaceutical Industry
Open Medicine
How industry uses medical writers to manipulate the medical literature

Off-Label Promotion, On-Target Sales
Public Library of Science
The covert promotion of drugs for unapproved uses

Thus Are Our Medical Meetings Managed (also read letter here)
British Medical Journal
Key opinion leaders may be unaware of pharma influence

Prescription Tracking and Public Health
Journal of General Internal Medicine
Why the AMA's opt-out plan does not protect prescribing privacy

Following the Script: How Drug Reps Make Friends and Influence Doctors
Public Library of Science
Psychological techniques reps use to sell drugs

Doctors Must Not be Lapdogs to Drug Firms
British Medical Journal
Drug reps stomp out of a talk about industry influence

“This May Sting a Bit”: Cutting CME’s Ties to Pharma
Virtual Mentor
CME should go pharma-free

Advertising in Medical Journals: Should Current Practices Change?
PLoS Medicine
Taking ads for luxury goods would be less compromising to medical journals than accepting only drug ads

Gynecologists and Estrogen: An Affair of the Heart
Perspectives in Biology and Medicine
Ob-gyns believe in HT despite evidence

Consumer Publications

Mammography and the Corporate Breast
Bioethics Forum

Ghostwritten Articles Helped Sell Hormones
Women's Health Activist

Bone-Breaking Drugs?
Women's Health Activist

Deceptive Market Practices in the Marketplace of Ideas
Bioethics Forum

Help Your Doctor Break the Sample Habit
Women's Health Activist

Smoke and Mirrors
Bioethics Forum

Hormones for Hot Flashes - Is "Natural" Better?
Women's Health Activist

Meds in Kids
Women's Health Activist

Classic Drugs Under Attack
Bioethics Forum

Hold the Hype on HPV
Women's Health Activist

Over-the-Counter Sales of Medical Records
Women's Health Activist

Cervical Cancer Vaccines in Context
Women's Health Activist

Less Hormone Therapy, Less Breast Cancer
Women's Health Activist

Big Pharma Wants to Know All About You
Women's Health Activist

A Bone to Pick with Bone Drugs
Women's Health Activist

Waiting Room Activism
Women's Health Activist

Why Race-Based Medicine is a Bad Idea
Women's Health Activist

Just Say No to New Drugs
Women's Health Activist

Other Materials

Letter to NIH: fund ethics research (pdf)

PharmedOut 2009 Annual Report (pdf)

No Drug Reps Certificate (pdf)

Unbiased Resources (doc)

How to Hold Pharma-free Meetings (pdf)

Prescription Drug Marketing: What Consumers Need to Know (pdf)

Fast Facts on Generics (pdf)

Drug Approval in the US: How Drugs get to Market (CME)

Generic Drugs: Prescribing Sensibly (CME)

The Physician-Pharma Relationship (powerpoint)

Bring Your Own Lunch (BYOL) Sandwich Guide (pdf)

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Drug Firms Turn to Private Docs to Promote Products
University ethics policies tightened Milwaukee Journal Sentinel

---

J&J Pushed Risperdal After Warning, Files Show
FDA ignored; CME supported off-label uses Bloomberg

---

NIH Should Disclose Financial Conflicts
Public database requested Pharmalot

---

Diabetes Heart Treatments May Cause Harm
Normalizing BP and postprandial hyperglycemia don't help NYT

---

Grassley Tells PBMs To Disclose Ties To Pharma
Drugmakers may provide financial benefits Pharmalot

---

Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ

---

States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune

---

Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle

---

Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal

---

Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT

---

Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT

---

Commentary

Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum

---

Click HERE to read the entire news archives